• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION THE Q-TRAK SUBCUTANEOUS ELECTRODE; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION THE Q-TRAK SUBCUTANEOUS ELECTRODE; IMPLANTABLE LEAD Back to Search Results
Model Number 3010
Device Problems High impedance (1291); Failure to Sense (1559); Defibrillation/Stimulation Problem (1573); Under-Sensing (1661); Low impedance (2285); Defective Device (2588)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/14/2021
Event Type  Injury  
Manufacturer Narrative
The product has been received for analysis.This report will be updated upon completion of analysis.
 
Event Description
It was reported that the patient underwent a replacement procedure for normal battery depletion.Prior to the procedure a 10 joule shock was delivered and yielded an impedance measurement of 120 ohms.It was noted that an x-ray had been taken a year earlier and indicated there was not a good electrode position.It was planned to first remove the capsule in the device pocket in order to lower the shock impedance.After the bag was closed and connected to the new device, another 10 joule synchronized shock with an impedance of 116 ohms occurred.They put the patient into ventricular fibrillation (vf) as desired by the physician, and the newly implanted s-icd detected the arrhythmia.Time to therapy was under 20 seconds.After the shock is delivered, a zero line appeared for about 10 seconds, but the patient still was in vf.The vf signals reappeared after approximately 10 more seconds, but the s-icd no longer detected every complex and no longer recognized a tachycardia arrhythmia.The shock impedance measurement was now at 3 ohms.External defibrillation was successful.Subsequently the new s-icd was attempted and not implanted.A new s-icd and electrode were implanted with no further issues and a shock impedance measurement of 72 ohms.No additional adverse patient effects were reported.
 
Manufacturer Narrative
The product has been received for analysis.This report will be updated upon completion of analysis.Upon receipt at our post market quality assurance laboratory, visual inspection revealed and coil deformation due to insulation abrasion.Resistance testing determined that the distal high voltage cable was fractured approximately 11.5 cm from the terminal pin.This type of damage is consistent with repeated stress over time.In this case, we believe the stress was the result of lead contact with another lead.The reported low out of range and high shock impedance measurements are likely the result of the lead damage observed by the laboratory.
 
Event Description
It was reported that the patient underwent a replacement procedure for normal battery depletion.Prior to the procedure a 10 joule shock was delivered and yielded an impedance measurement of 120 ohms.It was noted that an x-ray had been taken a year earlier and indicated there was not a good electrode position.It was planned to first remove the capsule in the device pocket in order to lower the shock impedance.After the bag was closed and connected to the new device, another 10 joule synchronized shock with an impedance of 116 ohms occurred.They put the patient into ventricular fibrillation (vf) as desired by the physician, and the newly implanted s-icd detected the arrhythmia.Time to therapy was under 20 seconds.After the shock is delivered, a zero line appeared for about 10 seconds, but the patient still was in vf.The vf signals reappeared after approximately 10 more seconds, but the s-icd no longer detected every complex and no longer recognized a tachycardia arrhythmia.The shock impedance measurement was now at 3 ohms.External defibrillation was successful.Subsequently the new s-icd was attempted and not implanted.A new s-icd and electrode were implanted with no further issues and a shock impedance measurement of 72 ohms.No additional adverse patient effects were reported.
 
Event Description
It was reported that the patient underwent a replacement procedure for normal battery depletion.Prior to the procedure a 10 joule shock was delivered and yielded an impedance measurement of 120 ohms.It was noted that an x-ray had been taken a year earlier and indicated there was not a good electrode position.It was planned to first remove the capsule in the device pocket in order to lower the shock impedance.After the bag was closed and connected to the new device, another 10 joule synchronized shock with an impedance of 116 ohms occurred.They put the patient into ventricular fibrillation (vf) as desired by the physician, and the newly implanted s-icd detected the arrhythmia.Time to therapy was under 20 seconds.After the shock is delivered, a zero line appeared for about 10 seconds, but the patient still was in vf.The vf signals reappeared after approximately 10 more seconds, but the s-icd no longer detected every complex and no longer recognized a tachycardia arrhythmia.The shock impedance measurement was now at 3 ohms.External defibrillation was successful.Subsequently the new s-icd was attempted and not implanted.A new s-icd and electrode were implanted with no further issues and a shock impedance measurement of 72 ohms.No additional adverse patient effects were reported.
 
Manufacturer Narrative
The product has been received for analysis.This report will be updated upon completion of analysis.Upon receipt at our post market quality assurance laboratory, visual inspection revealed and coil deformation due to insulation abrasion.Resistance testing determined that the distal high voltage cable was fractured approximately 11.5 cm from the terminal pin.This type of damage is consistent with repeated stress over time.In this case, we believe the stress was the result of lead contact with the device.The reported low out of range and high shock impedance measurements are likely the result of the lead damage observed by the laboratory.This report was filed to correct the text in the additional manufacturer narrative.There was an inadvertent typo that indicated lead on lead contact, however it should read lead on device contact.The text was updated.
 
Manufacturer Narrative
The product has been received for analysis.This report will be updated upon completion of analysis.Upon receipt at our post market quality assurance laboratory, visual inspection revealed and coil deformation due to insulation abrasion.Resistance testing determined that the distal high voltage cable was fractured approximately 11.5 cm from the terminal pin.This type of damage is consistent with repeated stress over time.In this case, we believe the stress was the result of lead contact with the device.The reported low out of range and high shock impedance measurements are likely the result of the lead damage observed by the laboratory.Upon receipt at our post market quality assurance laboratory, visual inspection noted insulation abrasion through to the conductor at 11.5 cm from the terminal pin.Resistance testing determined that the conductor measurement was discontinuous at the same location, which indicated there was no therapy available to the patient.The conductor coil was melted indicating the electrical conduction arced to the can of the s-icd.The appearance of the abrasion and conductor damage is consistent with repetitive lead contact with the s-icd over time.The reported abnormal defibrillation impedance measurements and oversensing are likely the result of the lead damage observed by the laboratory.This report was filed to correct the text in the additional manufacturer narrative.There was an inadvertent typo that indicated lead on lead contact, however it should read lead on device contact.The text was updated.
 
Event Description
It was reported that the patient underwent a replacement procedure for normal battery depletion.Prior to the procedure a 10 joule shock was delivered and yielded an impedance measurement of 120 ohms.It was noted that an x-ray had been taken a year earlier and indicated there was not a good electrode position.It was planned to first remove the capsule in the device pocket in order to lower the shock impedance.After the bag was closed and connected to the new device, another 10 joule synchronized shock with an impedance of 116 ohms occurred.They put the patient into ventricular fibrillation (vf) as desired by the physician, and the newly implanted s-icd detected the arrhythmia.Time to therapy was under 20 seconds.After the shock is delivered, a zero line appeared for about 10 seconds, but the patient still was in vf.The vf signals reappeared after approximately 10 more seconds, but the s-icd no longer detected every complex and no longer recognized a tachycardia arrhythmia.The shock impedance measurement was now at 3 ohms.External defibrillation was successful.Subsequently the new s-icd was attempted and not implanted.A new s-icd and electrode were implanted with no further issues and a shock impedance measurement of 72 ohms.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THE Q-TRAK SUBCUTANEOUS ELECTRODE
Type of Device
IMPLANTABLE LEAD
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
229 avenida fabricante
san clemente CA 92672
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key13328859
MDR Text Key284287738
Report Number2124215-2021-39945
Device Sequence Number1
Product Code LWS
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P110042/S000
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 09/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date09/01/2015
Device Model Number3010
Device Catalogue Number3010
Device Lot NumberA109023
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/13/2022
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/14/2021
Initial Date FDA Received01/22/2022
Supplement Dates Manufacturer Received08/09/2022
09/08/2022
09/08/2022
Supplement Dates FDA Received09/06/2022
09/08/2022
09/09/2022
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
-
-